share_log

藥明生物：翌日披露報表

WUXI BIO: Next Day Disclosure Return

香港交易所 ·  Feb 7 07:57
Summary by Moomoo AI
藥明生物技術有限公司於2024年2月7日完成一系列股份購回交易，根據香港聯合交易所有限公司證券上市規則披露詳情。該公司在2023年12月7日至2024年2月7日期間，進行了多次股份購回，總計購回股份達82,417,000股，佔已發行股份的1.93995%。最後一次購回發生在2024年2月7日，當日購回12,147,500股，每股價格介於HKD 18.9至HKD 19.7之間，總支付金額為HKD 233,505,070。此次股份購回未伴隨股份註銷。藥明生物確認所有交易均符合相關規定，並無重大變動。
藥明生物技術有限公司於2024年2月7日完成一系列股份購回交易，根據香港聯合交易所有限公司證券上市規則披露詳情。該公司在2023年12月7日至2024年2月7日期間，進行了多次股份購回，總計購回股份達82,417,000股，佔已發行股份的1.93995%。最後一次購回發生在2024年2月7日，當日購回12,147,500股，每股價格介於HKD 18.9至HKD 19.7之間，總支付金額為HKD 233,505,070。此次股份購回未伴隨股份註銷。藥明生物確認所有交易均符合相關規定，並無重大變動。
Pharmaceutical Biotechnology Limited completed a series of share repurchase transactions on 7 February 2024, in accordance with the disclosure details of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited. The company made several share repurchases between December 7, 2023 and February 7, 2024, for a total repurchase of 82,417,000 shares, representing 1.93995% of the issued shares. The last repurchase took place on 7 February 2024 and repurchased 12,147,500 shares at a price between HKD 18.9 and HKD 19.7 for a total payment of HKD 233,505,070. This share repurchase was not accompanied by a share write-off. Pharmacobiology confirms that all transactions comply with the relevant regulations and that there are no significant changes.
Pharmaceutical Biotechnology Limited completed a series of share repurchase transactions on 7 February 2024, in accordance with the disclosure details of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited. The company made several share repurchases between December 7, 2023 and February 7, 2024, for a total repurchase of 82,417,000 shares, representing 1.93995% of the issued shares. The last repurchase took place on 7 February 2024 and repurchased 12,147,500 shares at a price between HKD 18.9 and HKD 19.7 for a total payment of HKD 233,505,070. This share repurchase was not accompanied by a share write-off. Pharmacobiology confirms that all transactions comply with the relevant regulations and that there are no significant changes.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more